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ABSTRACT
Theendreplicationproblem,whichoccursinnormalsomaticcellsinducingreplica-
tive senescence, is solved in most cancer cells by activating telomerase. The activity
of telomerase is highly associated with carcinogenesis which makes the enzyme an
attractivebiomarkerincancerdiagnosisandtreatment.Theindolealkaloidharmine
hasmultiplepharmacologicalpropertiesincludingDNAintercalationwhichcanlead
to frame shift mutations. In this study, harmine was applied to human breast cancer
MCF-7 cells. Its activity towards telomerase was analyzed by utilizing the telomeric
repeat ampliﬁcation protocol (TRAP). Our data indicate that harmine exhibits a
pronouncedcytotoxicityandinducesananti-proliferationstateinMCF-7cellswhich
is accompanied by a signiﬁcant inhibition of telomerase activity and an induction
of an accelerated senescence phenotype by over-expressing elements of the p53/p21
pathway.
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INTRODUCTION
The end replication problem results in a continuous shortening of each end of a
chromosome. In most somatic cells the shortened fragments cannot be compensated.
Cells stop dividing when telomeres reach a critical length and replicative senescence is
initiated consequently. However, most cancer cells can conquer this obstacle because their
telomerase, a ribonucleoprotein that replicates telomere sequences at each cell division,
remains active. Telomerase is highly associated with carcinogenesis. It is detectable
in 85–90% of human cancers and over 70% of immortalized human cell lines (Kim
et al., 1994; Shay & Wright, 1996a; Shay & Wright, 1996b), whereas it is undetectable
in non-transformed somatic cells. Therefore, telomerase is an attractive target for the
developmentofanti-cancerdrugs.
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down-regulating hTERT mRNA expression accompanied by an accelerated senescent phenotype. PeerJ1:e174; DOI10.7717/peerj.174Telomerase is a cellular reverse transcriptase containing two components: A protein
element, telomerase reverse transcriptase (in human, hTERT) serving as catalytic subunit
and an RNA element, hTR, providing a template for telomere synthesis (Nakamura et al.,
1997).
Recent evidence suggests that increased telomere dysfunction leads to a loss of
chromosome end protection and induces the senescence state. But senescence can also
be induced without continuous telomere shortening suggesting that telomere integrity
is critical regardless of telomere length. Tumour suppressor proteins such as p53 are
required for the senescence arrest (Liu & Kulesz-Martin, 2001; Gorbunova, Seluanov &
Pereira-Smith,2002;Gewirtz,Holt&Elmore,2008).
Harmine, a naturally occurring -carboline alkaloid, has long been used in folk
medicine in the Middle East and in Asia (Sourkes, 1999) and as a hallucinogenic drug
(Wink & van Wyk, 2008). It was ﬁrst isolated from the seeds of Peganum harmala L. in
1874 (Budavari, 1989; Roberts & Wink, 1998; Wink & van Wyk, 2008; Wink, Schmeller
& Latz-Br¨ uning, 1998). Harmine has multiple pharmacological properties including
antiplasmodial activity (Astulla et al., 2008), antimutagenic and antiplatelet properties
(Im et al., 2009). In vitro studies demonstrate that the planar structure of harmine leads to
DNA intercalation. Since DNA intercalation causes frame shift mutations, these alkaloids
are known to be mutagenic, cytotoxic and antimicrobial (Roberts & Wink, 1998; Wink,
2007).Burgerandcolleaguesobserveddecadesagothatharminecouldinhibitmonoamine
oxidase (Burger & Nara, 1965) through which the metabolism of neurotransmitters are
modulated (Kim, Sablin & Ramsay, 1997; Wink, Schmeller & Latz-Br¨ uning, 1998). Recent
data indicate that harmine and related alkaloids act as agonists at serotonin receptors
(Wink, Schmeller & Latz-Br¨ uning, 1998; Glennon et al., 2000; Song et al., 2004). Harmine
and other -carboline alkaloids therefore exhibit hallucinogenic properties (Wink & van
Wyk,2008).
Dataobtainedfromcellviabilityassaysindicatethatharmineisapromisinginhibitorof
cellproliferationinavarietyofcancercelllines(Songetal.,2004).Itblocksthecellcycleat
G0/G1 phase (Hamsa & Kuttan, 2011) accompanied with a decrease of cyclin-dependent
kinase activity (Song et al., 2002; Song et al., 2004). DNA intercalation is also involved
in the inhibition of cell division as it prevents the transcription of several genes and
causes frame shift mutations. Previous ﬁndings indicate that telomeres are also a target
of intercalating drugs (Shammas et al., 2003; Shammas et al., 2004); they can induce very
stable G-quadruplex structures which cannot be replicated by telomerase (Burge et al.,
2006). Some known anticancer drugs exhibit DNA intercalation, such as isoquinoline,
quinoline,andindolealkaloids(Wink,Schmeller&Latz-Br¨ uning,1998;Wink,2007).
Among these alkaloids, the simple indole alkaloid harmine was identiﬁed in our labo-
ratory as a potent DNA intercalating and cytotoxic natural product (Rosenkranz & Wink,
2007). It has been reported that a few DNA-intercalating alkaloids, including berbamine
(Ji et al., 2002), chelidonine (Noureini & Wink, 2009) and 9-hydroxyellipticine (Sasaki
et al., 1992) are inhibitors of telomerase activity. Because harmine is an intercalating
and cytotoxic alkaloid a possible telomerase inhibition was evaluated in this research.
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MCF-7 cells and its possible interaction with telomerase. Anti-telomerase activity was
analyzed using the telomeric repeat ampliﬁcation protocol (TRAP). Harmine causes a
pronounced cytotoxicity and induces an anti-proliferation state in MCF-7 cells. This
process is accompanied by a signiﬁcant inhibition of telomerase activity and an induction
ofanacceleratedsenescencephenotypebyover-expressingp53/p21.
MATERIALS & METHODS
Chemicals
Harmine (C13H12N2O; MW 212.25) was purchased from Sigma-Aldrich. The stock
solution was prepared in dimethyl sulfoxide (DMSO) with a concentration of 100 M,
whichwasstoredat 20C.
Cell culture and harmine treatment
Human breast cancer cell line MCF-7 was kindly provided by Prof. Dr. S. W¨ olﬂ (IPMB,
Heidelberg University). Cells were routinely cultured in Dulbeccos’s Modiﬁed Eagle’s
Medium (DMEM, Invitrogen) supplemented with 2 mM glutamine, 100 U/ml penicillin,
100 g/ml streptomycin (Invitrogen, USA), and 10% heat-inactivated fetal bovine serum.
Cells were incubated at 37C in 5% CO2 and 100% humidity. Twenty-four h after plating,
cellsweretreatedwithharmineandincubateduptodiVerenttimepointsdependingonthe
experimentaldesign.ADMSOcontrolwasincludedineachanalysis.
Metabolic cell activity assay
Tenmicrolitersof3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazoliumbromide(MTT)
(5mg/ml)preparedinphosphate-buVeredsalinebuVerwereaddedtoeachwellaftergiven
time intervals; all plates were gently shaken by hands for several times and incubated at
37C for 3–4 h. At the end of incubation, the solution with MTT was carefully removed
and 100 l of lysis buVer (20% SDS in 1:1 N,N0-dimethylformamide: water/2% acetic
acid/2.5% HCl 1 M) was added per well. Then the plates were placed on a shaker at low
speedfor30minatroomtemperaturetoensurethattheformazanformedwascompletely
solubilized;itwasquantiﬁedbymeasuringtheODvalueat570nmina96-wellplatereader
(Spectramax384plus,MolecularDevices).
Telomerase activity assay
Proteins were isolated from MCF-7 cells with CHAPS lysis buVer (10 mM Tris-HCl, pH
7.5;1mMMgCl2,1mMEDTA,0.5%CHAPS,and10%glycerol).AllbuVersandsolutions
were prepared with RNase-free water. Telomerase activities was determined with 0.5 g
protein extract using TRAP as described previously (Kim et al., 1994). Brieﬂy, the protein
extract was ﬁrstly incubated with TS primer (50 AATCCGTCGAGCAGAGTT 30) for
30 min at 30C, after addition of CX primer (50 AATCCCATTCCCATTCCCATTCCC
30) the products were then subjected to PCR-ampliﬁcation at 94C for 30 s, and at 60C
30 s for 29 cycles. The PCR products were separated on a 12.5% polyacrylamide gel
by PAGE. The gel was stained with SYBR green (Amersham Biosciences) and directly
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a standard for the normalization of telomerase expression. The intensity of all bands were
photoscanned using ImageJ software (National Institutes of Health, America), the relative
telomeraseactivity(RTA)wasdeterminedbytheformula(Betts&King,1999).
RTA D
.s b/=ics
.pc b/=icpc
100
s:Intensityofsample
pc:Intensityofpositivecontrol
b:Intensityofbackground
ic:Intensityofinternalcontrol
Valuesareexpressedas%ofthecontrolsample.
Reverse transcription PCR of endogenous hTERT expression
Total RNA was isolated from MCF-7 cells using RNeasy kit (Qiagen, Germany). One
g of total RNA was reverse transcribed in a 20 L reaction volume using ImProm-
IITM Reverse Transcription System (Promega, Germany). A 1 L aliquot of cDNA
was analyzed by PCR ampliﬁcations. Global hTERT was ampliﬁed using the primer
50- CGGAAGAGTGTCTGGAGCAA-30 paired with 50-GGATGAAGCGGAGTCTGGA-30;
variant-hTERT was ampliﬁed with the primer 50-GCCTCAGCTGTACTTTGTCAA-30
paired with 50-CGCAAACAGCTTGTTCTCCATGTC-30. The thermocycling conditions
for global hTERT ampliﬁcation were: 94C 2 min followed by 33 cycles of 94C for 45 s,
60C for 45 s, and 72C for 90 s; for variant hTERT ampliﬁcation, the thermocycling
conditions were: 94C for 2 min followed by 35 cycles of 94C for 15 s, 60C for 15 s,
and 72C for 30 s. The housekeeping gene -actin was ampliﬁed with the primer
50-CCTGGCACCCAGCACAAT-30 paired with 50-GGGCCGGACTCGTCATAC-30 under
the same thermocycling conditions described above with only 20 cycles. Ampliﬁed
products (global hTERT: 145-bp; variant hTERT: full length variant, 457-bp;  variant,
421-bp; and  variant 275-bp; -actin: 143-bp) were separated by gel electrophoresis on a
2%agarosegelandvisualizedbyethidiumbromidestaining.
Semi-quantitative PCR analysis
One microliter of cDNA was applied in 10 L PCR reaction in capillaries containing
1SYBR Green Master Mix (ABgene), 0.3 M of each primer. A non-template control
was included as the negative control. The PCR reaction was performed in LightCycler3
(Roche, Germany) with initial 10 min denaturation at 95C, then followed with 45 cycles:
95C 10 s; 60C 10 s. All crossing point (cp) values were assessed by using REST software
relative to the expression of-actin. Primers which were used in Real-Time PCR are listed
inTable1.
-galactosidase staining
MCF-7 cells were incubated with harmine for 48 h or 96 h before -galactosidase activity
was determined. Then cells were washed twice in PBS and ﬁxed in ﬁxation solution
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Gene Primersequence(50–30)
-actin-f CCTGGCACCCAGCACAAT
-actin-r GGGCCGGACTCGTCATAC
2007hTERT-f ACGGCGACATGGAGAACAA
2007hTERT-r CACTGTCTTCCGCAAGTTCAC
p21-f TTTCTCTCGGCTCCCCATGT
p21-r GCTGTATATTCAGCATTGTGGG
Cdk2-f CCTCCTGGGCTGCAAATA
Cdk2-r CAGAATCTCCAGGGAATAGGG
p53-f TGCGTGTGGAGTATTTGGATG
p53-r TGGTACAGTCAGAGCCAACCAG
containing 2% formaldehyde and 0.2% glutaraldehyde for 5 min. The ﬁxation solution
was removed by washing the cells twice in PBS, and then the staining solution was added.
Cells were then incubated at 37C in a CO2 free environment for 8 h. The percentage of
positivelystainedcellswasdeterminedaftercountingthreerandomﬁeldsof100cellseach.
Representativemicroscopicﬁeldswerephotographedundera20objective.
Western blot analysis for p53 and p21waf-1 proteins
MCF-7 cells were treated with 20 M harmine for multiple time points (12, 24, 48,
and 96 h) prior to lysing the cells in Nonidet-P40 (NP40) lysis buVer (20 mM Tris,
pH 7.4, 150 mM NaCl, 5 mM EDTA, 1% NP40, and 10% glycerol). The constitutive
levelsof p53and p21waf1 wereassessed withrespect toisogenicuntreated MCF-7cultures.
Protein concentration was ﬁrstly determined with standard Bradford assay (Bradford,
1976), then a 25 g aliquot of the protein extract was separated on 12% of SDS-PAGE
and transferred onto a PVDF membrane (Millipore, Germany) by electroblotting. A
standard blotting protocol was then performed using p53 (DO1; Santa Cruz Biotech,
Germany) and a p21waf 1 monoclonal (BD Biosciences, Germany) antibody followed
by horseradish peroxidase-conjugated anti-mouse IgG (Dianova GmbH, Germany). An
enhanced chemiluminescent reaction (ECL Reagent, Amersham) was applied for the
detection.
RESULTS
Harmine is cytotoxic to MCF-7 cells in a dose- and time-dependent
manner and induces accelerated senescence
The cytotoxicity of harmine in MCF-7 cells is shown in Fig. 1. Cell viability at various
time points was determined by MTT assay. The results indicate that harmine arrests cell
growth in a dose- and time-dependent manner. Concentrations of 20 and 30 M harmine
signiﬁcantly reduced cell growth after 48 to 96 h. Concentrations between 10 and 20 M
did not inﬂuence viability of MCF-7 cells within the ﬁrst 24 h, and were therefore used in
thesubsequentexperiments.
Zhao and Wink (2013), PeerJ, DOI 10.7717/peerj.174 5/17Figure1 CytotoxicityofharmineinMCF-7cells. MCF-7 cells were incubated with harmine at diVerent
concentrations (0 M, 10 M, 20 M and 30 M) and multiple time periods (24 h, 48 h, 72 h and
96 h). Cell metabolic activity was determined by MTT assay. Viability of vehicle-treated samples was set
at 100%: 24 h, white bars; 48 h, black bars; 72 h, hatched bars; 96 h, dotted bars. Results are derived from
two independent experiments performed in quadruplicate (mean  SD).
Inthenextstepwetriedtostudywhethersenescentcellscouldbeidentiﬁedinresponse
to harmine treatment. In MCF-7 cells, harmine arrests cell proliferation and induces a
senescence morphology. -Galactosidase activity, as a senescence marker, was detectable
asearlyas2daftertreatmentwithharmine,andbecameintenseandexpressedinvirtually
every cell of the culture at day 4 (Fig. 2). Cells, which were -galactosidase positive, were
larger in size or multinucleated (indicated with arrows), both of which are morphological
features indicative of a senescent state. The SA--gal staining was not detected or barely
detectedinuntreatedcontrolcells.
Telomerase activity
Telomerase activity of MCF-7 cells, treated with or without harmine, was evaluated as
evidenced by the TRAP assay. A decreased telomerase activity (Fig. 3A) was detected after
the incubation of the cells with 20 M harmine. Telomerase activity was inhibited by
81.87% after 96 h treatment as compared to the untreated control (Fig. 3B). Treatment
at a lower concentration, e.g., 10 M, did not show a signiﬁcant reduction of telomerase
activity.
Expression analysis of human TERT splicing variants by RT-PCR
RT-PCRanalysiswasperformedwithapairofprimerswhichcoversallhTERTtranscripts.
In theory, four hTERT variants should be expected under the identical PCR conditions
at the same time (full length hTERT with 457 bp;  variant with 421 bp;  variant with
275 bp and  C variant with 239 bp). However, in our investigation, the  C variant
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-gal staining image of MCF-7 cells after harmine treat-
ment. MCF-7 cells were ﬁrstly treated with 20 M harmine for 48 h and 96 h, respectively. At the end of
treatment,SA--galstainingwasinvestigatedfollowingastandardprotocol.Allimagesweretakenat10
magniﬁcation. Percentage of -gal positive cells were quantiﬁed by ImageJ software. Graph established
from two independent areas (mean  S.D). p values indicate the signiﬁcant diVerence in positive -gal
staining for the sample treated with harmine with respect to the vehicle treated controls. Unpaired t test:
p  0:05; p  0:001.
could not be detected (Fig. 4A). Treatment of the cells with 20 M harmine signiﬁcantly
down-regulatedallhTERTsubunitsinatime-dependentmanner(Fig.4B).
Expression analysis of human TERT
Human hTERT, p21, and CDK2 mRNA transcripts were examined by real time PCR.
Data were analyzed by Relative Expression Software Tool (REST2008). PCR eYciency was
set as 2 as indicated by the software and the housekeeping gene -actin was regarded
as a control. A signiﬁcant up-regulation of p21 mRNA was detected as early as 12 h
after harmine treatment. The mRNA concentration was 3.9 fold higher than that of the
Zhao and Wink (2013), PeerJ, DOI 10.7717/peerj.174 7/17Figure3 EVectofharmineontelomeraseactivityinMCF-7cells. (A) MCF-7 cells were incubated with
harmineattwoconcentrations(10Mand20M)for24h,48h,72hand96h.Attheendofincubation,
telomerase activity was evaluated by applying TRAP assay; the TRAP products were then separated on a
12% PAGE gel and their intensity (all bands) was quantiﬁed by using ImageJ software and values were
plotted in (B): ctr, vehicle control, black bar; cells treated with 10 M of harmine, white bars; cells treated
with 20 M of harmine, dotted bars. Results derived from two independent experiments (mean  SD).
pvaluesindicatethesigniﬁcantchangesinrelativetelomeraseactivityforthesampletreatedwithharmine
with respect to the vehicle treated controls. Unpaired t test: p < 0:05; p  0:01.
Zhao and Wink (2013), PeerJ, DOI 10.7717/peerj.174 8/17Figure 4 Harmine inhibits telomerase expression in MCF-7 cells in a dose- and time-dependent
manner. (A) MCF-7 cells were incubated with harmine at ﬁnal concentration of 10 M and 20 M,
respectively, then total RNA was isolated and analyzed by using RT-PCR; (B) MCF-7 cells were incubated
with harmine at a ﬁnal concentration of 20 M for 48 h or 96 h, respectively, then total RNA was isolated
and analyzed by RT-PCR.
Figure 5 mRNA levels of hTERT, p21, and CDK2 in response to harmine treatment. MCF-7 cells were
exposedtoharmineataﬁnalconcentrationof20Mfor12h,24h,48hand96h,thenmRNAexpression
of each target gene was analyzed by real time PCR: hTERT, white bars; p21, black bars; CDK2, hatched
bars. Results are representative of two independent experiments in triplicate (mean  SD). p values
measure signiﬁcant changes in mRNA expression for the target gene treated with harmine with respect
to the vehicle treated controls. Unpaired t test: p > 0:05; p  0:01; p  0:001.
untreated control, and the up-regulation became 6.5 fold with respect to the control after
96 h (Fig. 5). Within the ﬁrst 24 h of treatment, no alteration of hTERT and CDK2 mRNA
expression was detected, while an extended treatment up to 48 h showed that a signiﬁcant
down-regulationwasobservedforthesetwogenes.
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We had shown before that harmine arrested MCF-7 cell growth and induced senescence
(Figs.1and2).Inordertodeﬁnethemechanismofharmine-inducedcellarrestaseriesof
immunoblot analyses were performed (Fig. 6A). MCF-7 cells were cultured with harmine
in a ﬁnal concentration of 20 M and cell samples were collected at diVerent time points
(24, 48, and 96 h). An enhanced expression of the phosphorylated H2AX (H2AX)
protein was detected after harmine treatment (Fig. 6B). An overexpressed p53 protein
was identiﬁed by immunoblot analysis as early as 24 h accompanied by an increased
p21 protein. c-Myc is a known transcriptional enhancer of hTERT expression. In our
investigation,c-Mycwasapparentlydown-regulated(Fig.6B).Comparedwiththechanges
inothergenes,thedecreaseofc-Mycwasmoremoderateinresponsetothetreatmentwith
harmine.
DISCUSSION
The indole alkaloid harmine exhibits multiple pharmacological properties in vivo and
in vitro (Wink & van Wyk, 2008; Wink & Schimmer, 2010). Among other eVects, harmine
signiﬁcantly arrests cell proliferation and induces cell death in a number of tumour cell
lines. A dose- and time-dependent cytotoxicity of harmine could be conﬁrmed in our
experimentswithMCF-7cells(Fig.1).
Cytotoxicity can result from an adverse interaction of harmine and other alkaloids
with one or more important targets present in a cell including DNA, RNA, or associated
enzymes (Roberts & Wink, 1998; Wink & van Wyk, 2008; Wink, 2007). Harmine is known
to intercalate DNA and can cause mutations and DNA damage (Wink, Schmeller &
Latz-Br¨ uning,1998;Wink&Schimmer,2010).Throughtheseinteractionscellproliferation
can be interrupted or cell death induced (Lansiaux et al., 2002; M¨ oller et al., 2007; Wink,
2007). In addition, the inhibition of cycline-dependent kinases such as CDK2 and CDK5
(Songetal.,2002)mightalsocontributetothecytotoxicityofharmine.Furthermore,ithas
beenshownthatharminecanrepresscytochromeP450activity(Tweedie,Prough&Burke,
1988)andselectivelyinhibitDNAtopoisomerase(Funayamaetal.,1996).
Another mechanism for cytotoxicity of alkaloids might involve the intercalation of
telomeresandtheinhibitionoftelomerase.SeveralDNA-intercalatingalkaloids,including
berbamine (Ji et al., 2002), chelidonine (Noureini & Wink, 2009) and 9-hydroxyellipticine
(Sasaki et al., 1992) could signiﬁcantly inhibit telomerase activity which could lead to the
interruption of the genomic stability as well as cell growth arrest (Shay & Bacchetti, 1997).
Becauseharmineisanintercalatingalkaloidapossibletelomeraseinhibitionwasevaluated
in this research. Indeed, as shown in our investigation, harmine induces a remarkable
reduction of telomerase activity in MCF-7 cells as measured by TRAP (a PCR-based assay
to detect telomerase activity) (Fig. 3). Harmine also triggers a signiﬁcant inhibition of
telomerase activity in Hela cells (Zhao, 2010), the concentrations applied in both cell lines
were very similar (20 M in MCF-7 cells, 30 M in HeLa cells). Under our experimental
condition, we did not ﬁnd the same senescent phenotype with HeLa cells. Also no
down-regulation could be detected on hTERT mRNA expression although telomerase
Zhao and Wink (2013), PeerJ, DOI 10.7717/peerj.174 10/17Figure 6 Harmine induces a general DNA damage response byover-expressing p53/p21 and
H2AX. (A) MCF-7 cells were incubated with harmine at 20 M for 24 h, 48 h and 96 h, then 25 g
of total protein extracted from cells after treatment of harmine or vehicle only was separated by PAGE
andanalyzedbyWesternblot.(B)changesinproteinlevelafterthetreatmentwerecalculatedwithrespect
to vehicle controls (100%): p21, black bars; p53, white bars; H2AX, grey bars; c-Myc, hatched bars.
activity was signiﬁcantly inhibited after harmine treatment. The mTOR pathway might
be involved and needs to be further investigated. The regulation of telomerase activity
involves various signalling pathways (Shay & Wright, 1996a; Shay & Wright, 1996b). It
is commonly accepted that the expression of hTERT is critical for telomerase activity
(Meyerson et al., 1997; Nakamura et al., 1997; Bodnar et al., 1998). The transcription of
hTERTmRNAwassigniﬁcantlydown-regulatedinresponsetoharminetreatment(Figs.4
and 5). The down-regulation became apparent about 24 h earlier than the reduction of
telomerase activity (TRAP assay) whereas no decrease in telomerase activity could be
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activity has a half-life longer than 24 h in almost all cell lines (Holt et al., 1997) whereas
the half-life of the hTERT mRNA is about 2 h (Xu et al., 1999). Our hypothesis is harmine
does not induce a direct inhibition on telomerase activity in MCF-7 cells but through
down-regulatinghTERTattranscriptionallevel.
Another factor could be c-Myc which plays an important role in the transcriptional
regulation of hTERT (Wu et al., 1999; Kyo et al., 2000). Overexpressed c-Myc protein leads
to a remarkable E-box dependent increase in the hTERT promoter activity. Moreover,
c-Myc could induce the expression of endogenous hTERT mRNA and telomerase activity
in normal human cells (Wang et al., 1998; Greenberg et al., 1999). In our experiments, a
time-dependentdown-regulationofcMycwasobserved(Fig.6)whichmightbecorrelated
withthedown-regulationofhTERT(Fig.4).
The tumor suppressor protein p53 is a nuclear transcription factor that accumulates
in response to cellular stress, including DNA damage and oncogene activation (Wink,
2007). P53 protein is a critical determinant of the cell fate following certain types of
DNA damage (Clarke et al., 1993; Liu & Kulesz-Martin, 2001). DNA damage triggers
transcriptional transactivation of p53 target genes such as p21, leading to cell cycle
arrest, senescence and/or apoptosis (Levine, 1997; Farnebo, Bykov & Wiman, 2010). P53
isessentialforbothsenescenceandapoptosispathways,speciﬁcally,incellcyclearrestatG1
phase; p53 enhances p21 transcription, which in turn inhibits CDK activity. As reported,
overexpressedwild-typep53couldinhibittelomeraseactivityviadown-regulatinghTERT
transcription (Gollahon et al., 1998; Kusumoto et al., 1999). However, such a reduction
cannot be directly achieved by p53 because the binding site between p53 and the hTERT
promoterismissing(Gualberto&Baldwin,1995;Bargonettietal.,1997;Kyoetal.,2000).
Inourstudy,p53wasoverexpressedafterharmineexposure(Fig.6);aninductioncould
be detected as early as 12 h after treatment. This enhancement was accompanied by an
increase in mRNA level as well as on protein level of p21 (Figs. 5 and 6). The question
arises as to whether the inhibition of hTERT is a consequence of overexpressed p53 or
harmine-induced cell cycle arrest. Harmine is able to interrupt DNA replication in vivo
(Boeira, Erdtmann & Henriques, 2001; Moura et al., 2007; Sasaki et al., 1992) and in vitro
(Wink, 2007). Other studies have found that harmine induces chromosome aberrations
andproducesDNAbreakageinculturedmammaliancells(Boeira,Erdtmann&Henriques,
2001). Moreover, harmine can inhibit topoisomerase I (Cao et al., 2005; Wink, Schmeller
& Latz-Br¨ uning, 1998), therefore blocking an important enzyme which can repair
DNA damage and ﬁx mutations (Sasaki et al., 1992; Wang, 1998). The accumulation of
phosphorylated H2AX (H2AX) is an early sign of genomic events reﬂecting induction of
double strands breaks (Tanaka et al., 2007; Albino et al., 2004). In this study, an increase
of H2AX was detected at 24 h after the treatment of harmine. Our hypothesis is that
intercalating harmine induces a general time-dependent DNA damage response. Instead
of triggering apoptosis, such damage apparently initiates an accelerated senescence in
MCF cells (Fig. 2). Similar results were obtained in other studies, in which MCF-7 cells
failed to undergo apoptotic cell death but underwent accelerated senescence after the
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the other hand, when p53 protein was diminished by infection with HPV-E6 oncogene,
MCF-7-E6cellsentereddelayedprogrammedcelldeath(Elmoreetal.,2002).Anumberof
studieshavedemonstratedthatreplicativesenescenceinducedbytelomereshorteningand
DNA damage-induced senescence leads to a very similar cell morphology (Oh et al., 2001;
Gorbunova, Seluanov & Pereira-Smith, 2002; Gewirtz, Holt & Elmore, 2008). Both events
involvetheparticipationofp53,themechanisms,however,remainunclear.
Inconclusion,thetreatmentofMCF-7cellswiththeDNAintercalatorharmineinduces
a time-dependent general DNA damage response. P53 senses the damage and stops cell
cycle progression by transactivating p21. Alternatively, the overexpressed p53 could
directly inhibit hTERT transcription. The inhibited telomerase could then facilitate cell
growtharrestinMCF-7cells,anddirectsdamagedcellsintoacceleratedsenescenceandnot
intoapoptoticpathway.
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